Acurx Pharmaceuticals, Inc. - stock earnings
ACXP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -5.1 million USD | ? USD |
| 2023Q3 | -3.1 million USD | ? USD |
| 2023Q2 | -3.4 million USD | ? USD |
| 2023Q1 | -2.9 million USD | ? USD |
| 2022Q4 | 2.0 million USD | ? USD |
| 2022Q3 | -3.5 million USD | ? USD |
| 2022Q2 | -2.6 million USD | ? USD |
| 2022Q1 | -2.7 million USD | ? USD |
| 2021Q4 | -2.6 million USD | ? USD |
| 2021Q3 | -4.6 million USD | ? USD |
| 2021Q2 | -4.0 million USD | ? USD |
| 2021Q1 | -1.5 million USD | ? USD |
| 2020Q4 | -1.1 million USD | ? USD |
| 2020Q3 | -1.3 million USD | ? USD |
| 2020Q2 | -913360 USD | ? USD |
| 2020Q1 | -1.3 million USD | ? USD |
ACXP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.6 million USD | ? USD |
| 2022 | -12.1 million USD | ? USD |
| 2021 | -12.7 million USD | ? USD |
| 2020 | -4.6 million USD | ? USD |
| 2019 | -5.9 million USD | ? USD |
ACXP
Price: $2.17
52 week price:
Earnings Per Share: -1.15 USD
P/E Ratio: -3.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 73400
Market Capitalization: 29.3 million